# To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer

> **NCT05432128** · — · UNKNOWN · sponsor: **Singlera Genomics Inc.** · enrollment: 600 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05432128
- **Lead sponsor:** Singlera Genomics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432128, "To Establish a Molecular Typing System for Early Diagnosis of Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05432128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*